Francesca Aroldi

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Sara Pusceddu, Claudio Vernieri, Massimo Di Maïo et al. · Gastroenterology · 2018 · 89 citations · Full text

Medicine, Endocrinology, Oncology +11

Tyrosine Kinase Inhibitors in EGFR-Mutated Large-Cell Neuroendocrine Carcinoma of the Lung A Case Report

Francesca Aroldi, Paola Bertocchi, Fausto Meriggi et al. · Case Reports in Oncology · 2014 · 27 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience

Laura Pizzuti, Antonio Giordano, Andrea Michelotti et al. · Journal of Cellular Physiology · 2018 · 27 citations · Full text

Medicine, Oncology, Pharmacology +15

Gemcitabine Plus Nab-Paclitaxel as Second-Line and Beyond Treatment for Metastatic Pancreatic Cancer: a Single Institution Retrospective Analysis

Paola Bertocchi, Chiara Abeni, Fausto Meriggi et al. · Reviews on Recent Clinical Trials · 2015 · 25 citations

Medicine, Oncology, Pharmacology +12

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

Sara Pusceddu, Francesco Barretta, Annalisa Trama et al. · Endocrine Related Cancer · 2018 · 23 citations · Full text

Medicine, Oncology, Surgery +17